KCAS Bio Advances Digital Transformation Through Partnership with Scispot

Scientific reporting automation and connected laboratory workflows support KCAS Bio's commitment to quality, data integrity and compliant study delivery.

KITCHENER, ON, Nov. 10, 2026 /CNW/ -- Scispot, a provider of AI-native laboratory operating systems, today announced its partnership with KCAS Bio, a global bioanalytical and biomarker contract research organization, to help advance KCAS Bio's digital transformation. The collaboration brings together KCAS Bio's scientific expertise and Scispot's laboratory automation capabilities to support the evolving needs of pharmaceutical and biotechnology sponsors.

Initial work focuses on automating scientific reporting, with a phased roadmap spanning inventory, dose formulation analysis, and connected laboratory workflows. The goal is to reduce repetitive data handling and report preparation, giving scientists more time for analysis, interpretation, and sponsor collaboration. Progress will be assessed through workflow cycle time and capacity measures.

"Our sponsors count on KCAS Bio for rigorous science, reliable data and a team that understands their development goals," said John Bucksath, CEO of KCAS Bio. "Digital transformation is an investment in those commitments. Working with Scispot, we are building an operation that can support our clients' growing needs while keeping quality central to how we work."

The initiative builds on KCAS Bio's established quality systems and independent quality assurance. Its focus on connected records and consistent documentation is intended to support data integrity, traceability and the scientific review processes behind compliant study delivery.

"Digital transformation should make scientific work easier to execute and easier to verify," said Guru Singh, founder and CEO of Scispot. "We are helping KCAS Bio connect its data and automate high-value workflows so its scientists can focus on the expertise sponsors depend on."

About KCAS Bio

KCAS Bio is a premier international provider of bioanalytical and laboratory services that provides comprehensive GLP- and GCP-compliant development services from early discovery support through commercial approval and beyond. One of only a select few CROs offering both large and small molecule development with extensive capabilities and expertise, KCAS Bio provides a truly differentiated approach to its clients who are looking for both scientific expertise and excellent customer service. KCAS Bio is headquartered in Olathe, Kansas – the Kansas City, KS metro area, supported by more than 380 employees. Further information can be found at www.KCASBio.com. 

About Scispot

Scispot is a provider of AI-native laboratory operating systems. The Canadian-headquartered company helps biotech, diagnostics, pharma, CRO/CDMO, bioproduction, biobanking, and testing teams coordinate lab execution as work happens across instruments, samples, workflows, approvals, data, and AI agents. Life sciences teams use Scispot to replace manual handoffs with connected, traceable operations, so they can run experiments, manage samples, review results, and generate reports with less manual coordination. For more information, visit www.scispot.com

SOURCE Scispot

Cody Boekestyn, [email protected]